Selumetinib in the Treatment of Symptomatic Intractable Plexiform Neurofibromas in Neurofibromatosis Type 1: A Prospective Case Series with Emphasis on Side Effects.
Francesco BaldoAntonio Giacomo GrassoLuisa Cortellazzo WielAlessandra MaestroMarta Paulina TrojniakFlora Maria MurruLuca BassoAndrea MagnolatoIrene BrunoEgidio BarbiPublished in: Paediatric drugs (2020)
In this case series, selumetinib appears to be effective and safe for the pediatric population.
Keyphrases